Tala A Haddad, Ahmad A Toubasi, Abdallah Fahmawi, Ali Zaid
{"title":"Clinical Outcomes of PCI in Hospitals With or Without Surgical Backup: A Meta-analysis.","authors":"Tala A Haddad, Ahmad A Toubasi, Abdallah Fahmawi, Ali Zaid","doi":"10.1177/00033197251326354","DOIUrl":null,"url":null,"abstract":"<p><p>Percutaneous coronary interventions (PCIs) have seen a steady rise. Recent guidelines have established that PCIs conducted at non-surgical on-site (NSOS) facilities have low complication rates and outcomes comparable to surgical on-site (SOS) centers. However, differing perspectives in the growing literature continue to sustain controversy. A thorough literature review was performed across four databases, including PubMed, Cochrane Library, Scopus, and Web of Science, to identify studies comparing outcomes between hospitals. The primary endpoints were: 30-day mortality, myocardial infarction (MI), cerebral vascular accident (CVA), emergency coronary artery bypass surgery (eCABG), rePCI, and target vessel revascularization (TVR). The final search yielded 22 studies, including a total of 2,181,897 patients. The majority of patients (71.9%) underwent PCI in SOS hospitals. There was a significant association of increased eCABG (OR = 1.99; 95% CI: 1.08-3.67) and rePCI (OR = 1.62; 95% CI: 1.37-1.91) rates in SOS hospitals. However, 30-day mortality (OR = 0.91; 95% CI: 0.53-1.54), MI (OR = 1.08; 95% CI: 0.91-1.28), CVA (OR = 1.13; 95% CI: 0.69-1.86), and TVR (OR = 1.06; 95% CI: 0.92-1.21) showed no significant difference between hospitals. Subgroup analyses among clinical trials and ST-segment elevation myocardial infarction (STEMI) patients found no significant associations. Conclusively, this meta-analysis provides updated insight into the impact of SOS on PCI outcomes, having no difference except for eCABG and rePCI rates.</p>","PeriodicalId":8264,"journal":{"name":"Angiology","volume":" ","pages":"33197251326354"},"PeriodicalIF":2.6000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Angiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00033197251326354","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Percutaneous coronary interventions (PCIs) have seen a steady rise. Recent guidelines have established that PCIs conducted at non-surgical on-site (NSOS) facilities have low complication rates and outcomes comparable to surgical on-site (SOS) centers. However, differing perspectives in the growing literature continue to sustain controversy. A thorough literature review was performed across four databases, including PubMed, Cochrane Library, Scopus, and Web of Science, to identify studies comparing outcomes between hospitals. The primary endpoints were: 30-day mortality, myocardial infarction (MI), cerebral vascular accident (CVA), emergency coronary artery bypass surgery (eCABG), rePCI, and target vessel revascularization (TVR). The final search yielded 22 studies, including a total of 2,181,897 patients. The majority of patients (71.9%) underwent PCI in SOS hospitals. There was a significant association of increased eCABG (OR = 1.99; 95% CI: 1.08-3.67) and rePCI (OR = 1.62; 95% CI: 1.37-1.91) rates in SOS hospitals. However, 30-day mortality (OR = 0.91; 95% CI: 0.53-1.54), MI (OR = 1.08; 95% CI: 0.91-1.28), CVA (OR = 1.13; 95% CI: 0.69-1.86), and TVR (OR = 1.06; 95% CI: 0.92-1.21) showed no significant difference between hospitals. Subgroup analyses among clinical trials and ST-segment elevation myocardial infarction (STEMI) patients found no significant associations. Conclusively, this meta-analysis provides updated insight into the impact of SOS on PCI outcomes, having no difference except for eCABG and rePCI rates.
期刊介绍:
A presentation of original, peer-reviewed original articles, review and case reports relative to all phases of all vascular diseases, Angiology (ANG) offers more than a typical cardiology journal. With approximately 1000 pages per year covering diagnostic methods, therapeutic approaches, and clinical and laboratory research, ANG is among the most informative publications in the field of peripheral vascular and cardiovascular diseases. This journal is a member of the Committee on Publication Ethics (COPE). Average time from submission to first decision: 13 days